Home

Craig C. Hopkinson

CIK 1730048 · EVP R&D, Chief Medical Officer · last filed 2026-08-03

Craig C. Hopkinson is an EVP R&D, Chief Medical Officer who has filed 77 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for ALKS, was dated Aug 3, 2026. Across all open-market trades the lifetime net is −$24.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.36M

Companies

2

Total Filings

77

Lifetime Open-Market Net

-$24.32M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ALKS EVP R&D, Chief Medical Officer 69,389 $48.37 $3.36M -$24.32M 54 2026-08-03
ALBIREO PHARMA, INC. (ALBO) Delisted Director 10,495 $44.15 $463.4K $0 2 2023-03-02

Recent Filings

77 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-03 ALKS Notice (144) −9,000 -$437.2K EDGAR
2026-08-03 ALKS Mixed −4,000 -$314.8K EDGAR
2026-07-01 ALKS Notice (144) −9,000 -$463.6K EDGAR
2026-07-01 ALKS Mixed −4,000 -$366.9K EDGAR
2026-06-01 ALKS Notice (144) −9,000 -$375.0K EDGAR
2026-06-01 ALKS Mixed −4,000 -$278.3K EDGAR
2026-05-01 ALKS Notice (144) −9,000 -$300.6K EDGAR
2026-05-01 ALKS Mixed −4,000 -$203.9K EDGAR
2026-04-01 ALKS Notice (144) −9,000 -$319.6K EDGAR
2026-04-01 ALKS Mixed −4,000 -$222.9K EDGAR
Showing 1–10 of 77
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.